Capricor Therapeutics Inc (CAPR)

12:07 PM

How analysts rate Capricor Therapeutics Inc. stock todayJuly 2025 Weekly Recap & Reliable Intraday Trade Plans - newser.com

12:07 PM

11:30 AM

Historical volatility pattern of Capricor Therapeutics Inc. visualizedGDP Growth & Stepwise Trade Execution Plans - newser.com

11:30 AM

10:28 AM

Heatmap analysis for Capricor Therapeutics Inc. and competitors2025 Price Momentum & Community Verified Trade Alerts - newser.com

10:28 AM

05:33 AM

How Capricor Therapeutics Inc. stock reacts to job market dataQuarterly Earnings Report & AI Based Buy/Sell Signal Reports - newser.com

05:33 AM

01:53 AM

Capricor Therapeutics : Investor PresentationOctober 2025 - MarketScreener

01:53 AM

01:31 AM

What institutional flow reveals about Capricor Therapeutics Inc.2025 Price Targets & Community Consensus Picks - newser.com

01:31 AM

Oct 12, 2025

Capricor Therapeutics, Inc. (CAPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Oct 12, 2025

Oct 10, 2025

Can trapped investors hope for a rebound in Capricor Therapeutics Inc.New Guidance & Long-Term Safe Investment Plans - newser.com

Oct 10, 2025

Oct 10, 2025

Is a relief rally coming for Capricor Therapeutics Inc. holdersWeekly Risk Summary & Daily Profit Focused Screening - newser.com

Oct 10, 2025

Oct 09, 2025

Weiss Ratings Reaffirms "Sell (D-)" Rating for Capricor Therapeutics (NASDAQ:CAPR) - MarketBeat

Oct 09, 2025

Oct 09, 2025

Capricor Therapeutics, Inc. (CAPR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Oct 09, 2025

Oct 09, 2025

Will Capricor Therapeutics Inc. (4LN2) stock outperform energy sector in 2025Weekly Loss Report & Community Driven Trade Alerts - newser.com

Oct 09, 2025

Oct 08, 2025

CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire

Oct 08, 2025

Oct 07, 2025

Capricor Therapeutics Inc Stock Analysis and ForecastMomentum Stock Picks & Minimal Investment Capital Gains - earlytimes.in

Oct 07, 2025

Oct 07, 2025

What drives Capricor Therapeutics Inc 4LN2 stock priceMarket Correction Analysis & Affordable Market Insights - earlytimes.in

Oct 07, 2025

Oct 06, 2025

Will Capricor Therapeutics Inc. stock see PE expansionInsider Buying & Free Verified High Yield Trade Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Volume spikes in Capricor Therapeutics Inc. stock – what they meanWeekly Market Report & Daily Technical Forecast Reports - newser.com

Oct 06, 2025

Oct 06, 2025

Will Capricor Therapeutics Inc. (4LN2) stock profit from AI boom2025 Market Overview & Growth Focused Investment Plans - newser.com

Oct 06, 2025

Oct 06, 2025

Is Capricor Therapeutics Inc. stock resilient to inflationJuly 2025 Technicals & Community Supported Trade Ideas - newser.com

Oct 06, 2025

Oct 06, 2025

New Drug for Duchenne Muscular Dystrophy Nears Potential Approval - streetwisereports.com

Oct 06, 2025

Oct 05, 2025

Capricor Therapeutics Inc. recovery potential after sell off2025 Sector Review & Safe Entry Zone Tips - newser.com

Oct 05, 2025

Oct 05, 2025

Published on: 2025-10-05 04:39:29 - newser.com

Oct 05, 2025

Oct 05, 2025

Is Capricor Therapeutics Inc. (4LN2) stock a good hedge against inflation2025 Top Gainers & Community Verified Swing Trade Signals - newser.com

Oct 05, 2025

Oct 04, 2025

User - FinancialContent

Oct 04, 2025

Oct 03, 2025

Capricor Therapeutics, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation - GlobeNewswire

Oct 03, 2025

Oct 03, 2025

There's Reason For Concern Over Capricor Therapeutics, Inc.'s (NASDAQ:CAPR) Massive 26% Price Jump - 富途牛牛

Oct 03, 2025

Oct 03, 2025

Head to Head Review: Baxter International (NYSE:BAX) and Capricor Therapeutics (NASDAQ:CAPR) - Defense World

Oct 03, 2025

Oct 02, 2025

Largest borrow rate increases among liquid names - TipRanks

Oct 02, 2025

Oct 01, 2025

Biotech Secures FDA Alignment on Late-Stage Duchenne Therapy - streetwisereports.com

Oct 01, 2025

Oct 01, 2025

Biotech Battles FDA, Target Price Shows Potential 90% Gains - streetwisereports.com

Oct 01, 2025

Sep 30, 2025

Hope On The Horizon As Capricor's HOPE-3 Trial For Duchenne Muscular Dystrophy Nears Data Readout - RTTNews

Sep 30, 2025

Sep 30, 2025

Is ICICI Prudential Asset Management Co Ltd Stock a Strong Buy According to Wall StreetGlobal Trade Effects & Free Stock Trading Workshops - earlytimes.in

Sep 30, 2025

Sep 30, 2025

What analysts say about Capricor Therapeutics Inc stockRetail Trading Trends & Low Cost Stock Picks - earlytimes.in

Sep 30, 2025

Sep 29, 2025

Can Sagardeep Alloys Limited Deliver DoubleDigit Returns in the Next YearStock Liquidity Analysis & Free Stop-Loss Planning for Your Portfolio - earlytimes.in

Sep 29, 2025

Sep 29, 2025

Capricor: Post-CRL Path To DMD Cardiomyopathy Approval In 2026 (NASDAQ:CAPR) - Seeking Alpha

Sep 29, 2025

Sep 29, 2025

Why analysts maintain buy rating on Capricor Therapeutics Inc. (4LN2) stock2025 Top Gainers & Trade Opportunity Analysis - newser.com

Sep 29, 2025